Resources
August 13, 2020- Aetion In a recent interview, Kathryn Starzyk, epidemiologist and Head of Real-World Evidence (RWE) at OM1, shared what makes OM1’s data unique, and how she and her team partner with biopharma and health systems to generate RWE that helps researchers better understand patient journeys in disease areas including rheumatology and immunology. Read on[…]
August 11, 2020 – HealthEconomics.com “Correctly identifying a patient with a rare disease can be like looking for a needle in a haystack”, according to Dr. Joseph Zabinski, Director, AI & Precision Medicine at OM1. But what if we could apply a magnet to the haystack, taking advantage of ‘hidden’ properties that – even without[…]
Collaboration enables otolaryngologists and researchers to leverage data for real-world evidence, outcomes, and personalized medicine programs BOSTON, May 13, 2020 — OM1, a real-world outcomes and technology company, today announced a strategic partnership with the American Academy of Otolaryngology–Head and Neck Surgery Foundation (AAO-HNSF) connecting the Foundation’s Reg-entSM clinical data registry to OM1’s real-world data[…]
May 12, 2020 – Annals of Internal Medicine Richard E. Gliklich, MD; Michelle B. Leavy, MPH; Lisa Cosgrove, PhD; Gregory E. Simon, MD, MPH; Bradley N. Gaynes, MD, MPH; Lars E. Peterson, MD, PhD; Bryan Olin, PhD; Collette Cole, RN, BSN; J. Raymond DePaulo Jr., MD; Philip Wang, MD, DrPH; Chris M. Crowe, PhD; Cristina[…]
Published by TechCrunch, December 17 2019, written by Jonathan Shieber OM1, a big-data analytics company for the healthcare industry, has raised $50 million in its latest round of financing to expand its sales and marketing and product development activities as it brings clinical insights to hospitals and big pharma companies alike. The new financing highlights[…]
